Amcor plc

ticker: AMCR step: 01 generated: 2026-05-13 source: quick-research

Amcor plc (AMCR) — Business Overview

Business Description

Amcor is a global leader in flexible and rigid packaging solutions, headquartered in Zürich, Switzerland and listed on NYSE (American depositary shares). The company serves food, beverage, pharmaceutical, healthcare, and personal care customers in over 140 countries. On April 30, 2025, Amcor completed an all-stock combination with Berry Global ($8.4B deal), creating the world's largest flexible packaging company with approximately $23B in combined revenues, 400 facilities, 70,000 employees, and a significantly expanded healthcare and hygiene packaging portfolio. Amcor's fiscal year ends June 30.

Revenue Model

Revenue comes from manufacturing and selling flexible packaging (films, pouches, flexible bags), rigid packaging (bottles, jars, closures), and healthcare packaging (pharmaceutical blister packs, medical device packaging). Packaging is a volume-plus-price business — Amcor benefits from global CPG volume growth while passing through raw material (resin, aluminum foil) price changes to customers via contractual mechanisms. The Berry combination dramatically expands the rigid plastics and healthcare segments.

Products & Services

• Flexible packaging: films, pouches, stand-up bags, lidding, wraps (food, personal care, pet food)
• Rigid packaging: plastic bottles, jars, closures (beverages, food, personal care)
• Healthcare packaging: pharmaceutical blister packs, medical device pouches, sterile packaging
• Specialty applications: coffee packaging, protein packaging, hygiene/beauty packaging
• Sustainable packaging: recyclable, compostable, reduced-plastic formats

Customer Base & Go-to-Market

Global CPG companies: Nestlé, Unilever, P&G, Mars, PepsiCo, and major pharmaceutical companies. Relationships are typically multi-year supply agreements at the global brand level. The combined Amcor-Berry portfolio strengthens positions in healthcare (high-margin), protein, pet food, liquids, beauty, and foodservice — all structurally growing categories.

Competitive Position

World's largest flexible packaging company post-Berry. Major competitors include Sealed Air, Sonoco, Graphic Packaging (fiber), and Constantia Flexibles (private). The scale advantage of $23B+ in revenues provides procurement leverage on resins (largest input cost), customer diversification, and the R&D budget to lead on sustainable packaging innovation — increasingly important as CPG customers face ESG mandates.

Key Facts

• Founded: 1926 (as Australian Consolidated Industries packaging operations)
• Headquarters: Zürich, Switzerland (operational HQ: Zürich; incorporated in UK)
• Employees: ~70,000 (post-Berry combination)
• Exchange: NYSE (ADR)
• Sector / Industry: Materials / Containers & Packaging (Flexible & Rigid)
• Market Cap: ~$18–22B (post-combination)

ticker: AMCR step: 04 generated: 2026-05-13 source: quick-research

Amcor plc (AMCR) — Financial Snapshot

Income Statement Summary (FY ends June 30)

FY2024 revenue declined 7.2% as consumer destocking and volume normalization post-COVID impacted flexible packaging demand. FY2025 revenue rebounded to $15.0B (+10%) as volumes recovered and Berry Global was included from April 30, 2025 (2 months of Berry in FY2025). FY2025 GAAP net income fell 30% to $511M due to Berry integration costs of $262M in restructuring/transaction expenses.

Cash Flow & Balance Sheet (FY2025, post-Berry)

Key Ratios (approximate)

• P/E: ~25x (trailing; inflated by integration costs) | Dividend Yield: ~4.2%
• Revenue Growth (FY2025): +10% (Berry contribution) | FCF Margin: ~6–7%
• Debt/Equity: ~1.2x | Interest Coverage: ~2x (stretched post-merger)

Growth Profile

Amcor's organic revenue growth averages 3% per year — a mature, stable packaging business. The transformative event is the April 2025 Berry Global merger: the combined company doubles its employee count (41,000 → 77,000), adds rigid dispensing, healthcare, and beauty packaging to the portfolio, and creates $650M in targeted synergies by FY2028. FY2026 is the first full year with Berry — expected $260M in pre-tax synergies will drive ~12% adjusted EPS accretion vs. standalone Amcor.

Forward Estimates

• FY2026: First full year with Berry; $260M pre-tax synergies → ~12% adj. EPS accretion
• FY2028 targets: $650M total synergies + $280M one-time cash benefits + $3B+ annual cash flow
• Annual dividend: $0.50/share (raised from $0.485 — consecutive annual increases for 30+ years)
• Integration costs: $262M incurred in 9 months ended March 2026 (near peak)
• Analyst guidance: 72–76 cents adj. EPS for FY2025; FY2026 meaningfully higher with synergies

ticker: AMCR step: 12 generated: 2026-05-13 source: quick-research

Amcor plc (AMCR) — Investment Catalysts & Risks

Bull Case Drivers

1. Berry Global Synergy Capture — Amcor acquired Berry Global in an all-stock deal, driving 68% YoY sales growth and 120 bps EBITDA margin expansion. Management targets $260M in synergies by FY26 and $650M fully realized by FY28, pushing free cash flow toward $2.1B. Guidance was raised to FY26 adjusted EPS of $3.98–$4.03, reflecting strong integration progress.

2. Dividend Growth & Free Cash Flow Yield — Amcor raised its quarterly dividend to $0.65/share, reflecting confidence in cash generation post-merger. The stock offers a ~5% dividend yield and ~10% FCF yield, positioning it as a high-income compounder. Dividend growth is supported by leverage declining as integration proceeds.

3. Healthcare & Sustainability Tailwinds — The Berry acquisition shifts Amcor's mix toward higher-margin healthcare and hygiene packaging segments. Sustainability mandates (recyclable and reduced-plastic packaging) align with Amcor's product roadmap, and emerging-market expansion in Asia and Latin America offers long-term volume growth as packaged goods penetration rises.

Bear Case Risks

1. Stretched Balance Sheet & Integration Risk — The Berry merger significantly elevated Amcor's leverage (debt/equity ~1.2x, interest coverage ~2x). Maintaining investment-grade ratings requires disciplined debt paydown, and any execution missteps in integration — cost overruns, cultural friction, or delayed divestitures — could pressure the balance sheet and compress the stock.

2. Volume Trends & Margin Compression — Despite synergy optimism, near-term EPS is below pre-merger levels and margins remain thin in flexible packaging. Consumer staples destocking, private label shifts, and resin cost volatility are ongoing headwinds. If volume growth disappoints, synergy-driven EPS improvement could take longer to materialize.

3. Execution Risk on Portfolio Pruning — Management's strategy includes divestitures of lower-margin businesses and a shift to a calendar fiscal year with new Miami headquarters. Asset sales depend on buyer appetite and valuations; if divestitures are delayed or fetch lower-than-expected prices, leverage stays elevated longer and the synergy story loses momentum.

Upcoming Events

• FY2026 Q4 (Aug 2026): Full-year results — first complete fiscal year post-Berry acquisition close
• FY2026: $260M synergy milestone checkpoint
• 2026: Transition to calendar fiscal year and Miami HQ relocation

Analyst Sentiment

Analysts are broadly constructive with a Hold-to-Buy consensus and price targets implying 20–30% upside based on peer EV/EBITDA comps, though near-term caution persists around leverage, synergy execution, and thin packaging margins. The high dividend yield provides a floor for income-oriented investors.

Research Date

Generated: 2026-05-13